XML 90 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Interim Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]        
Research and development, net $ (1,169) $ (1,617) $ (5,724) $ (7,736)
General and administrative (1,215) (1,302) (4,131) (5,545)
Operating loss (2,384) (2,919) (9,855) (13,281)
Financing income, net 13 66 228 118
Loss on disposal of property and equipment     (2) (5)
Loss on legal settlement, net     (1,111)
Net loss $ (2,371) $ (2,853) $ (10,740) $ (13,168)
Basic net loss per share $ (0.17) $ (0.36) $ (1.05) $ (1.81)
Diluted net loss per share $ (0.17) $ (0.36) $ (1.05) $ (1.81)
Basic weighted average common shares outstanding 14,055,973 8,013,295 10,199,984 7,260,344
Diluted weighted average common shares outstanding 14,055,973 8,013,295 10,199,984 7,260,344